• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Astronics Corporation Reports 2025 Third Quarter Financial Results

    11/4/25 4:15:00 PM ET
    $ATRO
    Military/Government/Technical
    Industrials
    Get the next $ATRO alert in real time by email
    • Third quarter sales increased 3.8% to $211.4 million driven by Aerospace growth of 8.5% to $192.7 million
    • Third quarter net loss was $11.1 million, reflecting $32.6 million in refinancing-related charges; adjusted EBITDA1 was $32.7 million, or 15.5% of sales
    • Aerospace operating margin was 16.2% and adjusted operating margin1 was 16.7%
    • Solid quarterly bookings of $210.4 million and backlog of $646.7 million
    • Generated $34.2 million in cash from operations
    • Refinancing activities included the issuance of a convertible bond during the third quarter and the initiation of a cash flow revolver subsequent to quarter end
    • Expect fourth quarter revenue to be $225 to $235 million, resulting in 2025 revenue expectation of $847 to $857 million

    Astronics Corporation (NASDAQ:ATRO) ("Astronics" or the "Company"), a leading supplier of advanced technologies and products to the global aerospace, defense, and other mission critical industries, today reported financial results for the three and nine months ended September 27, 2025.

    Peter J. Gundermann, Chairman, President and Chief Executive Officer, commented, "We had a solid third quarter, demonstrating continued operational progress to meet strong customer demand with revenue stabilizing above $200 million per quarter. Strong sales supported operating margin expansion, reflecting both meaningful operating leverage on increased volume and the impact of our profitability initiatives. Recent refinancing actions provide us with enhanced financial flexibility and greater liquidity to support our business while minimizing potential dilution in the future. The refinancing combined with the market demand we are experiencing sets us up for a strong finish to 2025 and an exciting 2026."

    Third Quarter Results

     

     

    Three Months Ended

     

    Nine Months Ended

     

    ($ in thousands)

    September 27,

    2025

     

    September 28,

    2024

     

    % Change

     

    September 27,

    2025

     

    September 28,

    2024

     

    % Change

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Sales

    $

    211,447

     

     

    $

    203,698

     

     

    3.8

    %

     

    $

    622,061

     

     

    $

    586,886

     

     

    6.0

    %

     

    Gross Profit

    $

    64,511

     

     

    $

    55,224

     

     

    16.8

    %

     

    $

    178,187

     

     

    $

    158,306

     

     

    12.6

    %

     

    Gross Margin

     

    30.5

    %

     

     

    27.1

    %

     

     

     

     

    28.6

    %

     

     

    27.0

    %

     

     

     

    Income from Operations

    $

    23,055

     

     

    $

    8,374

     

     

    175.3

    %

     

    $

    40,950

     

     

    $

    17,590

     

     

    132.8

    %

     

    Operating Margin %

     

    10.9

    %

     

     

    4.1

    %

     

     

     

     

    6.6

    %

     

     

    3.0

    %

     

     

     

    Loss on Settlement of Debt

    $

    32,644

     

     

    $

    6,987

     

     

     

     

    $

    32,644

     

     

    $

    6,987

     

     

     

     

    Net Loss

    $

    (11,098

    )

     

    $

    (11,738

    )

     

    5.5

    %

     

    $

    (256

    )

     

    $

    (13,383

    )

     

    98.1

    %

     

    Net Loss %

     

    (5.2

    )%

     

     

    (5.8

    )%

     

     

     

     

    —

    %

     

     

    (2.3

    )%

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted Operating Income2

    $

    25,931

     

     

    $

    19,589

     

     

    32.4

    %

     

    $

    66,833

     

     

    $

    37,701

     

     

    77.3

    %

    Adjusted Operating Margin %2

     

    12.3

    %

     

     

    9.6

    %

     

     

     

     

    10.7

    %

     

     

    6.4

    %

     

     

     

    Adjusted Net Income2

    $

    19,404

     

     

    $

    12,163

     

     

    59.5

    %

     

    $

    50,118

     

     

    $

    21,287

     

     

    135.4

    %

     

    Adjusted EBITDA2

    $

    32,718

     

     

    $

    27,059

     

     

    20.9

    %

     

    $

    88,865

     

     

    $

    64,927

     

     

    36.9

    %

     

    Adjusted EBITDA Margin %2

     

    15.5

    %

     

     

    13.3

    %

     

     

     

     

    14.3

    %

     

     

    11.1

    %

     

     

     

    Third Quarter 2025 Results (compared with the prior-year period, unless noted otherwise)

    Growth in sales was driven by the Aerospace segment's continued strength in demand primarily from the Commercial Transport market. Aerospace sales increased $15.2 million, or 8.5%, which more than offset a $7.4 million decline in Test Systems sales.

    Gross profit increased $9.3 million to $64.5 million, or 30.5% of sales, an improvement over gross margin of 27.1% in the comparator quarter, primarily attributable to higher volume, pricing initiatives and improved productivity. Third quarter gross profit in the prior year was negatively impacted by a $3.5 million atypical warranty reserve.

    Tariff expense in the current quarter was approximately $4 million. Based on current tariff rates in effect today, Astronics believes the potential incremental impact to annual costs of materials related to direct and known indirect effects is in the range of $15 million to $20 million before mitigation and assuming no exemptions for aerospace-related products. The Company believes that certain actions including pass-through pricing, supply chain restructuring, duty drawbacks, the implementation of free trade zones, and other operational adjustments will significantly reduce the anticipated impacts of tariffs over time. The Company expects that tariff rates will remain in flux in the near future and will refine its strategy as the situation becomes more stable.

    In the third quarter of 2025, selling, general and administrative expenses ("SG&A") decreased $3.1 million. Litigation-related expenses were down $4.3 million, somewhat offset by $1.2 million in higher legal and accounting expenses related to acquisitions. R&D was down $2.3 million reflecting the timing of projects. The prior-year period was negatively impacted by $1.3 million in reserves related to the bankruptcy filing of an Aerospace customer.

    Operating margin expansion of 680 basis points and adjusted operating margin2 expansion of 270 basis points was the result of leverage on higher volume, improved productivity in the Aerospace segment, coupled with savings from the recent Test Systems cost rationalization activities.

    A $32.6 million Loss on Settlement of Debt was the result of certain costs incurred related to the partial repurchase of convertible notes due 2030 discussed in the Balance Sheet and Liquidity section below, compared to a Loss on Settlement of Debt of $7.0 million in the prior year.

    Interest expense was down $3.3 million, or 53.0%, on lower rates following 2024 refinancing activities. Tax benefit in the quarter was $1.2 million compared with a tax expense of $6.6 million in the prior-year period, mostly as a result of a valuation allowance reversal associated with research and development costs that are expected to be expensed for tax purposes in the current year under the One Big Beautiful Bill Act.

    Consolidated net loss of $0.31 per diluted share improved from a net loss of $0.34 per diluted share in the prior-year period from the strength in sales and profitability that more than offset the incremental loss on settlement of debt. Adjusted net income2 per share increased $0.15 per diluted share, or 44%, to $0.49 per diluted share, demonstrating the impact of stronger profitability and lower interest expense.

    Consolidated adjusted EBITDA2 increased 20.9% to $32.7 million and was 15.5% of consolidated sales. The Company is targeting high teen to 20% or better adjusted EBITDA2 margins.

    Bookings of $210.4 million in the quarter resulted in a book-to-bill ratio of 1.00:1. For the trailing twelve months, bookings totaled $863.0 million and the book-to-bill ratio was 1.04:1. Backlog at the end of the quarter was $646.7 million.

    Aerospace Segment Review (compared with the prior-year period, unless noted otherwise)

    Aerospace segment sales of $192.7 million increased $15.2 million, or 8.5%. Sales in the Commercial Transport market increased $15.4 million, or 11.5%. Growth was primarily related to increased demand by airlines for cabin power, seat motion and system certification products and services. Military Aircraft sales increased $5.9 million, or 27.1%, to $27.6 million, driven by increased demand for lighting and safety products. General Aviation sales decreased $4.2 million, or 23.0%, to $13.9 million due to lower airframe power and inflight entertainment & connectivity ("IFEC") product sales to the VVIP market due to the timing of programs. Other sales decreased $1.9 million as the Company has wound down its non-core contract manufacturing arrangements.

    Aerospace segment operating profit of $31.2 million, or 16.2% of sales, improved over the prior-year period reflecting the leverage gained on higher volume, pricing initiatives, and improving production efficiencies, combined with a $4.4 million decrease in litigation-related expenses. The prior year was impacted by a $3.5 million atypical warranty reserve and a non-cash reserve associated with a customer bankruptcy of $2.2 million. Adjusted Aerospace operating profit2 increased 27.1% to $32.1 million, or 16.7% of sales, a 240-basis point expansion over the comparator quarter.

    Aerospace bookings were $191.9 million for a book-to-bill ratio of 1.00:1. Backlog for the Aerospace segment was $572.5 million at quarter end.

    Mr. Gundermann commented, "Our Aerospace business had a strong third quarter achieving a 16.2% operating margin, well surpassing our near-term margin target and a testament to its potential. Sales also reflected the consistent improvement in demand we are seeing. We believe the tailwinds driving our Aerospace business will accelerate as we close out 2025 and continue into 2026 and beyond."

    Test Systems Segment Review (compared with the prior-year period, unless noted otherwise)

    Test Systems segment sales of $18.7 million were down $7.4 million from the comparator quarter in 2024. The decrease was driven by lower sales of radio test sets in general as full rate production for the U.S. Army program has not yet begun.

    Test Systems segment operating profit was near break-even in both periods. Test Systems continues to be negatively affected by mix and under absorption of fixed costs at current volume levels.

    Bookings for the Test Systems segment in the quarter were $18.5 million. The book-to-bill ratio was 0.99:1 for the quarter. Backlog for the Test Systems segment was $74.3 million at quarter end.

    Mr. Gundermann commented, "Our Test business had a break-even operating profit on relatively low sales, which demonstrates the significant cost-cutting initiatives we have implemented across the business. We expect it will become profitable once our radio test program begins for the U.S. Army. We expect to receive production orders near year-end or shortly thereafter."

    Balance Sheet and Liquidity

    Cash provided by operations in the third quarter of 2025 was $34.2 million, reflecting higher cash earnings and lower working capital requirements. Capital expenditures in the quarter were $13.2 million.

    Long-term debt, net of cash, increased $164.2 million to $314.4 million at quarter end compared with $150.2 million at the end of 2024. On September 16, 2025, the Company issued $225 million aggregate principal amount of 0% Convertible Senior Notes for net proceeds of approximately $217 million. The Notes will mature on January 15, 2031, unless earlier converted, redeemed or repurchased. The Company will settle the principal in cash and has the flexibility to settle any premium in stock, cash or a combination of both. The conversion price of the 0% Convertible Senior Notes is $54.87; however, as the Company also purchased capped call options, there is no potential dilution unless the stock price exceeds the upper strike price of $83.41.

    The Company used net proceeds from the offering in part to repurchase approximately $132.0 million, or 80%, of the aggregate principal amount of its 5.500% Convertible Senior Notes due 2030 and pay the $26.9 million cost for the capped calls. Subsequent to the repurchase, there was $33 million of principal outstanding on the Notes due 2030. Borrowings of $85.0 million under the ABL Revolving Credit Facility and $11.0 million in cash provided the balance of payment for the repurchase of the Notes due 2030. In addition to the costs that were required to be recorded as an expense in the income statement, as discussed above, other repurchase-related costs, including the cost of the capped call, were required to be classified as a reduction of shareholders' equity. As a result, shareholders' equity has decreased by $152.4 million.

    The refinancing resulted in the elimination of approximately 5.8 million shares of potential dilution. Approximately 1.44 million shares of potential dilution remain under the outstanding 5.500% Convertible Senior Notes due 2030.

    Subsequent to the end of the quarter, on October 22, 2025, the Company entered into a new $300 million senior secured, cash flow-based revolving credit facility (the "New Revolver"). The New Revolver matures in October 2030 and replaces the previous ABL Revolving Credit Facility that was scheduled to mature in 2027. The New Revolver, which enhances financial flexibility to support the Company's growth initiatives, also has an accordion feature, which allows the Company to request incremental commitments of up to $100 million plus additional incremental amounts so long as maximum leverage requirements are met.

    The New Revolver will accrue interest at a floating rate equal to SOFR plus the applicable margin ranging from 125 basis points to 213 basis points based on leverage.

    The Company had available liquidity of $111.9 million at the end of the third quarter.

    Nancy L. Hedges, Chief Financial Officer, commented, "Our execution on the financing events to repurchase 80% of the $165 million of 5.5% Notes due 2030 was a proactive move to both eliminate future potential dilution of almost 5.8 million shares as well as measurably reduce the future cost of conversion. The continued appreciation in our stock price above the $22.89 conversion price was making the cost of future cash settlement very expensive. Given the tailwinds we see in the aerospace and defense industries and the opportunities to meaningfully grow revenue and earnings, we felt this was an opportune time to execute the refinancing and take advantage of current capital markets trends which allowed us to issue a 0% convertible bond. While the accounting treatment was complex, and our balance sheet now has more debt and less equity, the end result is less dilution, lower cost of conversion, lower cost of debt and greater financial flexibility. We believe this was an action that benefits our shareholders both now and in the years to come."

    Updated 2025 Outlook

    Astronics expects fourth quarter sales to be in the range of $225 to $235 million, a significant step up from the prior three quarters of the year. Total revenue for the year is expected to be in the range of $847 to $857 million, which would establish a record annual sales level for the Company. The midpoint of the revised range would be a 7.2% increase over 2024 sales.

    Backlog at the end of the third quarter was $646.7 million, of which approximately 74% is expected to be recognized as revenue over the next twelve months. Planned capital expenditures in 2025 are expected to be in the range of $40 million to $50 million subject to the timing of spending related to a facility consolidation and build-out for its Seattle operations.

    Mr. Gundermann commented, "We expect to have a strong finish to 2025, while establishing a new sales record in the fourth quarter. We anticipate that market conditions will stay strong, and our revenue level will stay elevated through 2026. While we are not ready to issue guidance at this time, our early look suggests we should see low double-digit growth for next year. We believe 2026 will be a very good year for Astronics."

    Third Quarter 2025 Webcast and Conference Call

    The Company will host a teleconference today at 4:45 p.m. ET. During the teleconference, management will review the financial and operating results for the period and discuss Astronics' corporate strategy and outlook. A question-and-answer session will follow.

    The Astronics conference call can be accessed by calling (201) 493-6784. The listen-only audio webcast can be monitored at investors.astronics.com. To listen to the archived call, dial (412) 317-6671 and enter replay pin number 13755702. The telephonic replay will be available from 8:00 p.m. on the day of the call through Tuesday, November 18, 2025. The webcast replay can be accessed via the investor relations section of the Company's website where a transcript will also be posted once available.

    About Astronics Corporation

    Astronics Corporation (NASDAQ:ATRO) serves the world's aerospace, defense, and other mission-critical industries with proven innovative technology solutions. Astronics works side-by-side with customers, integrating its array of power, connectivity, lighting, structures, interiors, and test technologies to solve complex challenges. For over 50 years, Astronics has delivered creative, customer-focused solutions with exceptional responsiveness. Today, global airframe manufacturers, airlines, military branches, completion centers, and Fortune 500 companies rely on the collaborative spirit and innovation of Astronics. The Company's strategy is to increase its value by developing technologies and capabilities that provide innovative solutions to its targeted markets.

    Safe Harbor Statement

    This news release contains forward-looking statements as defined by the Securities Exchange Act of 1934. One can identify these forward-looking statements by the use of the words "expect," "anticipate," "plan," "may," "will," "estimate," "feeling" or other similar expressions and include all statements with regard to the Company's fourth quarter and full year 2025 outlook, the amount of capital expenditures for 2025, the amount of the impact of tariffs on costs for materials to the Company and level of mitigation potential with respect thereto, the amount of backlog to be recognized as revenue over the next twelve months, the strength and length of time associated with tailwinds for the Aerospace segment, the achievement of profitability in the Test segment, elevated revenue in 2026 that approaches double digits, and statements regarding the strategy of the Company and its outlook. Forward-looking statements also include all statements related to achieving any revenue or profitability expectations, expectations of continued growth, the level of liquidity, the level of cash generation, the level of demand by customers and markets and the amount of expected capital expenditures. Because such statements apply to future events, they are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated by the statements. Important factors that could cause actual results to differ materially from what may be stated here include the trend in growth with passenger power and connectivity on airplanes, the state of the aerospace and defense industries, the market acceptance of newly developed products, internal production capabilities, the timing of orders received, the status of customer certification processes and delivery schedules, the demand for and market acceptance of new or existing aircraft which contain the Company's products, the impact of regulatory activity and public scrutiny on production rates of a major U.S. aircraft manufacturer, the need for new and advanced test equipment, customer preferences and relationships, the effectiveness of the Company's supply chain, and other factors which are described in filings by Astronics with the Securities and Exchange Commission. Except as required by applicable law, the Company assumes no obligation to update forward-looking information in this news release whether to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results, financial conditions or prospects, or otherwise.

    Use of Non-GAAP Financial Metrics and Additional Financial Information

    In addition to reporting financial results in accordance with generally accepted accounting principles, or GAAP, Astronics provides Adjusted Non-GAAP information as additional information for its operating results. References to Adjusted Non-GAAP information are to non-GAAP financial measures. These measures are not required by, in accordance with, or an alternative for, GAAP and may be different from non-GAAP financial measures used by other companies. Astronics management uses these measures for reviewing the financial results of Astronics for budget planning purposes and for making operational and financial decisions. Management believes that providing these non-GAAP financial measures to investors, as a supplement to GAAP financial measures, help investors evaluate Astronics core operating and financial performance and business trends consistent with how management evaluates such performance and trends.

    FINANCIAL TABLES FOLLOW

    ASTRONICS CORPORATION

    CONSOLIDATED STATEMENT OF OPERATIONS DATA

    (Unaudited, $ in thousands except per share amounts)

     

     

     

     

     

     

    Three Months Ended

     

    Nine Months Ended

     

    9/27/2025

     

    9/28/2024

     

    9/27/2025

     

    9/28/2024

    Sales

    $

    211,447

     

     

    $

    203,698

     

     

    $

    622,061

     

     

    $

    586,886

     

    Cost of products sold

     

    146,936

     

     

     

    148,474

     

     

     

    443,874

     

     

     

    428,580

     

    Gross profit3

     

    64,511

     

     

     

    55,224

     

     

     

    178,187

     

     

     

    158,306

     

    Gross margin

     

    30.5

    %

     

     

    27.1

    %

     

     

    28.6

    %

     

     

    27.0

    %

     

     

     

     

     

     

     

     

    Research and development expenses

     

    10,210

     

     

     

    12,481

     

     

     

    32,849

     

     

     

    40,018

     

    Selling, general and administrative

     

    31,246

     

     

     

    34,369

     

     

     

    104,388

     

     

     

    100,698

     

    SG&A % of sales

     

    14.8

    %

     

     

    16.9

    %

     

     

    16.8

    %

     

     

    17.2

    %

    Income from operations

     

    23,055

     

     

     

    8,374

     

     

     

    40,950

     

     

     

    17,590

     

    Operating margin

     

    10.9

    %

     

     

    4.1

    %

     

     

    6.6

    %

     

     

    3.0

    %

     

     

     

     

     

     

     

     

    Loss on settlement of debt

     

    32,644

     

     

     

    6,987

     

     

     

    32,644

     

     

     

    6,987

     

    Other (income) expense

     

    (185

    )

     

     

    343

     

     

     

    (562

    )

     

     

    1,214

     

    Interest expense, net

     

    2,920

     

     

     

    6,217

     

     

     

    9,167

     

     

     

    17,832

     

    Loss before tax

     

    (12,324

    )

     

     

    (5,173

    )

     

     

    (299

    )

     

     

    (8,443

    )

    Income tax (benefit) expense

     

    (1,226

    )

     

     

    6,565

     

     

     

    (43

    )

     

     

    4,940

     

    Net loss

    $

    (11,098

    )

     

    $

    (11,738

    )

     

    $

    (256

    )

     

    $

    (13,383

    )

    Net loss % of sales

     

    (5.2

    )%

     

     

    (5.8

    )%

     

     

    —

    %

     

     

    (2.3

    )%

     

     

     

     

     

     

     

     

    Basic loss per share:

    $

    (0.31

    )

     

    $

    (0.34

    )

     

    $

    (0.01

    )

     

    $

    (0.38

    )

    Diluted loss per share:4

    $

    (0.31

    )

     

    $

    (0.34

    )

     

    $

    (0.01

    )

     

    $

    (0.38

    )

     

     

     

     

     

     

     

     

    Weighted average diluted shares outstanding (in thousands)

     

    35,423

     

     

     

    35,011

     

     

     

    35,372

     

     

     

    34,961

     

    ASTRONICS CORPORATION

    CONSOLIDATED BALANCE SHEETS

    ($ in thousands)

     

    (unaudited)

     

     

     

    9/27/2025

     

    12/31/2024

    ASSETS

     

     

     

    Cash and cash equivalents

    $

    13,479

     

     

    $

    9,285

     

    Restricted cash

     

    6,101

     

     

     

    9,143

     

    Accounts receivable, net of allowance for estimated credit losses

     

    188,630

     

     

     

    191,446

     

    Inventories

     

    197,290

     

     

     

    199,741

     

    Prepaid expenses and other current assets

     

    27,149

     

     

     

    16,557

     

    Total current assets

     

    432,649

     

     

     

    426,172

     

    Property, plant and equipment, net of accumulated depreciation

     

    96,635

     

     

     

    80,687

     

    Operating right-of-use assets

     

    33,769

     

     

     

    23,609

     

    Other assets

     

    8,297

     

     

     

    7,763

     

    Intangible assets, net of accumulated amortization

     

    51,083

     

     

     

    52,477

     

    Goodwill

     

    59,760

     

     

     

    58,056

     

    Total assets

    $

    682,193

     

     

    $

    648,764

     

     

     

     

     

    LIABILITIES AND SHAREHOLDERS' EQUITY

     

     

     

    Current liabilities:

     

     

     

    Accounts payable

    $

    51,683

     

     

    $

    42,960

     

    Current operating lease liabilities

     

    6,019

     

     

     

    4,697

     

    Accrued expenses and other current liabilities

     

    66,597

     

     

     

    81,004

     

    Customer advances and deferred revenue

     

    26,709

     

     

     

    27,491

     

    Total current liabilities

     

    151,008

     

     

     

    156,152

     

    Long-term debt

     

    334,019

     

     

     

    168,669

     

    Long-term operating lease liabilities

     

    39,349

     

     

     

    20,508

     

    Other liabilities

     

    48,909

     

     

     

    47,338

     

    Total liabilities

     

    573,285

     

     

     

    392,667

     

    Shareholders' equity:

     

     

     

    Common stock

     

    381

     

     

     

    380

     

    Accumulated other comprehensive loss

     

    (2,020

    )

     

     

    (3,863

    )

    Other shareholders' equity

     

    110,547

     

     

     

    259,580

     

    Total shareholders' equity

     

    108,908

     

     

     

    256,097

     

    Total liabilities and shareholders' equity

    $

    682,193

     

     

    $

    648,764

     

    ASTRONICS CORPORATION

    CONSOLIDATED CASH FLOWS DATA

     

    Nine Months Ended

    (Unaudited, $ in thousands)

    9/27/2025

     

    9/28/2024

    Cash flows from operating activities:

     

     

     

    Net loss

    $

    (256

    )

     

    $

    (13,383

    )

    Adjustments to reconcile net loss to cash from operating activities:

     

     

     

    Non-cash items:

     

     

     

    Depreciation and amortization

     

    16,129

     

     

     

    18,572

     

    Amortization of deferred financing fees

     

    1,805

     

     

     

    2,711

     

    Provisions for non-cash losses on inventory and receivables

     

    6,062

     

     

     

    8,023

     

    Equity-based compensation expense

     

    5,341

     

     

     

    6,414

     

    Deferred tax benefit

     

    (1,125

    )

     

     

    —

     

    Loss on settlement of debt

     

    32,644

     

     

     

    6,987

     

    Operating lease non-cash expense

     

    4,659

     

     

     

    3,869

     

    Simplification initiative-related non-cash charges

     

    6,229

     

     

     

    —

     

    Non-cash 401K contribution and quarterly bonus accrual

     

    —

     

     

     

    3,454

     

    Non-cash annual stock bonus accrual

     

    —

     

     

     

    1,448

     

    Other

     

    (756

    )

     

     

    2,899

     

    Cash flows from changes in operating assets and liabilities:

     

     

     

    Accounts receivable

     

    5,190

     

     

     

    (22,712

    )

    Inventories

     

    (7,140

    )

     

     

    (19,829

    )

    Accounts payable

     

    8,271

     

     

     

    (3,304

    )

    Accrued expenses

     

    (14,719

    )

     

     

    13,517

     

    Income taxes

     

    (11,513

    )

     

     

    798

     

    Operating lease liabilities

     

    (3,125

    )

     

     

    (3,777

    )

    Tenant improvement allowance refund

     

    3,157

     

     

     

    —

     

    Customer advance payments and deferred revenue

     

    (2,317

    )

     

     

    (2,919

    )

    Supplemental retirement plan liabilities

     

    (539

    )

     

     

    (309

    )

    Other assets and liabilities

     

    (825

    )

     

     

    1,690

     

    Net cash provided by operating activities

     

    47,172

     

     

     

    4,149

     

    Cash flows from investing activities:

     

     

     

    Capital expenditures

     

    (19,860

    )

     

     

    (5,244

    )

    Acquisition of business, net of cash acquired

     

    (4,617

    )

     

     

    —

     

    Net cash used by investing activities

     

    (24,477

    )

     

     

    (5,244

    )

    Cash flows from financing activities:

     

     

     

    Proceeds from long-term debt

     

    86,143

     

     

     

    195,978

     

    Principal payments on long-term debt

     

    (11,143

    )

     

     

    (187,498

    )

    Proceeds from issuance of convertible debt

     

    225,000

     

     

     

    —

     

    Partial repurchase of 2030 notes

     

    (285,752

    )

     

     

    —

     

    Payments for capped call transactions

     

    (26,888

    )

     

     

    —

     

    Financing-related costs

     

    (8,127

    )

     

     

    (9,073

    )

    Stock award activity

     

    (1,730

    )

     

     

    (3,219

    )

    Other

     

    (109

    )

     

     

    (96

    )

    Net cash used by financing activities

     

    (22,606

    )

     

     

    (3,908

    )

    Effect of exchange rates on cash

     

    1,063

     

     

     

    54

     

    Increase (decrease) in cash and cash equivalents and restricted cash

     

    1,152

     

     

     

    (4,949

    )

    Cash and cash equivalents and restricted cash at beginning of period

     

    18,428

     

     

     

    11,313

     

    Cash and cash equivalents and restricted cash at end of period

    $

    19,580

     

     

    $

    6,364

     

    Supplemental disclosure of cash flow information

     

     

     

    Non-cash investing activities:

     

     

     

    Capital expenditures in accounts payable

    $

    2,796

     

     

    $

    —

     

    Interest paid

    $

    7,593

     

     

    $

    15,261

     

    Income taxes refunded, net of payments

    $

    12,636

     

     

    $

    3,975

     

    ASTRONICS CORPORATION

    SEGMENT SALES AND PROFIT

    (Unaudited, $ in thousands)

     

     

     

     

    Three Months Ended

     

    Nine Months Ended

     

    9/27/2025

     

    9/28/2024

     

    9/27/2025

     

    9/28/2024

    Sales

     

     

     

     

     

     

     

    Aerospace

    $

    192,725

     

     

    $

    177,564

     

     

    $

    577,760

     

     

    $

    518,187

     

    Less inter-segment

     

    —

     

     

     

    (10

    )

     

     

    (34

    )

     

     

    (52

    )

    Total Aerospace

     

    192,725

     

     

     

    177,554

     

     

     

    577,726

     

     

     

    518,135

     

     

     

     

     

     

     

     

     

    Test Systems

     

    18,752

     

     

     

    26,183

     

     

     

    44,685

     

     

     

    68,790

     

    Less inter-segment

     

    (30

    )

     

     

    (39

    )

     

     

    (350

    )

     

     

    (39

    )

    Total Test Systems

     

    18,722

     

     

     

    26,144

     

     

     

    44,335

     

     

     

    68,751

     

     

     

     

     

     

     

     

     

    Total consolidated sales

     

    211,447

     

     

     

    203,698

     

     

     

    622,061

     

     

     

    586,886

     

     

     

     

     

     

     

     

     

    Segment gross profit and margins5

     

     

     

     

     

     

     

    Aerospace

     

    60,462

     

     

     

    49,817

     

     

     

    173,836

     

     

     

    148,217

     

     

     

    31.4

    %

     

     

    28.1

    %

     

     

    30.1

    %

     

     

    28.6

    %

    Test Systems

     

    4,049

     

     

     

    5,407

     

     

     

    4,351

     

     

     

    10,089

     

     

     

    21.6

    %

     

     

    20.7

    %

     

     

    9.8

    %

     

     

    14.7

    %

    Total gross profit

     

    64,511

     

     

     

    55,224

     

     

     

    178,187

     

     

     

    158,306

     

     

     

    30.5

    %

     

     

    27.1

    %

     

     

    28.6

    %

     

     

    27.0

    %

    Segment operating profit and margins

     

     

     

     

     

     

     

    Aerospace

     

    31,167

     

     

     

    14,251

     

     

     

    71,470

     

     

     

    45,628

     

     

     

    16.2

    %

     

     

    8.0

    %

     

     

    12.4

    %

     

     

    8.8

    %

    Test Systems

     

    (14

    )

     

     

    (13

    )

     

     

    (8,947

    )

     

     

    (8,428

    )

     

     

    (0.1

    )%

     

     

    —

    %

     

     

    (20.2

    )%

     

     

    (12.3

    )%

    Total segment operating profit

     

    31,153

     

     

     

    14,238

     

     

     

    62,523

     

     

     

    37,200

     

     

     

     

     

     

     

     

     

    Loss on settlement of debt

     

    32,644

     

     

     

    6,987

     

     

     

    32,644

     

     

     

    6,987

     

    Interest expense

     

    2,920

     

     

     

    6,217

     

     

     

    9,167

     

     

     

    17,832

     

    Corporate expenses and other

     

    7,913

     

     

     

    6,207

     

     

     

    21,011

     

     

     

    20,824

     

    Loss before taxes

    $

    (12,324

    )

     

    $

    (5,173

    )

     

    $

    (299

    )

     

    $

    (8,443

    )

    ASTRONICS CORPORATION

    SALES BY MARKET

    (Unaudited, $ in thousands)

     

     

     

     

     

     

    Three Months Ended

     

    Nine Months Ended

    2025 YTD

     

    9/27/2025

    9/28/2024

    % Change

     

    9/27/2025

    9/28/2024

    % Change

    % of Sales

    Aerospace Segment

     

     

     

     

     

     

     

     

    Commercial Transport

    $

    149,209

    $

    133,850

    11.5

    %

     

    $

    432,324

    $

    383,679

    12.7

    %

    69.6

    %

    Military Aircraft

     

    27,554

     

    21,685

    27.1

    %

     

     

    88,250

     

    63,545

    38.9

    %

    14.2

    %

    General Aviation

     

    13,919

     

    18,077

    (23.0

    )%

     

     

    47,532

     

    56,643

    (16.1

    )%

    7.6

    %

    Other

     

    2,043

     

    3,942

    (48.2

    )%

     

     

    9,620

     

    14,268

    (32.6

    )%

    1.5

    %

    Aerospace Total

     

    192,725

     

    177,554

    8.5

    %

     

     

    577,726

     

    518,135

    11.5

    %

    92.9

    %

     

     

     

     

     

     

     

     

     

    Test Systems Segment

     

     

     

     

     

     

     

     

    Government & Defense

     

    18,722

     

    26,144

    (28.4

    )%

     

     

    44,335

     

    68,751

    (35.5

    )%

    7.1

    %

     

     

     

     

     

     

     

     

     

    Total Sales

    $

    211,447

    $

    203,698

    3.8

    %

     

    $

    622,061

    $

    586,886

    6.0

    %

     

    SALES BY PRODUCT LINE

    (Unaudited, $ in thousands)

     

     

     

     

     

     

    Three Months Ended

     

    Nine Months Ended

    2025 YTD

     

    9/27/2025

    9/28/2024

    % Change

     

    9/27/2025

    9/28/2024

    % Change

    % of Sales

    Aerospace Segment

     

     

     

     

     

     

     

     

    Electrical Power & Motion

    $

    101,295

    $

    90,467

    12.0

    %

     

    $

    296,541

    $

    263,919

    12.4

    %

    47.8

    %

    Lighting & Safety

     

    51,654

     

    46,921

    10.1

    %

     

     

    154,324

     

    135,162

    14.2

    %

    24.8

    %

    Avionics

     

    26,168

     

    29,151

    (10.2

    )%

     

     

    91,452

     

    83,716

    9.2

    %

    14.7

    %

    Systems Certification

     

    7,938

     

    4,460

    78.0

    %

     

     

    15,842

     

    12,272

    29.1

    %

    2.5

    %

    Structures

     

    3,627

     

    2,613

    38.8

    %

     

     

    9,947

     

    8,798

    13.1

    %

    1.6

    %

    Other

     

    2,043

     

    3,942

    (48.2

    )%

     

     

    9,620

     

    14,268

    (32.6

    )%

    1.5

    %

    Aerospace Total

     

    192,725

     

    177,554

    8.5

    %

     

     

    577,726

     

    518,135

    11.5

    %

    92.9

    %

     

     

     

     

     

     

     

     

     

    Test Systems Segment

     

    18,722

     

    26,144

    (28.4

    )%

     

     

    44,335

     

    68,751

    (35.5

    )%

    7.1

    %

     

     

     

     

     

     

     

     

     

    Total Sales

    $

    211,447

    $

    203,698

    3.8

    %

     

    $

    622,061

    $

    586,886

    6.0

    %

     

    ASTRONICS CORPORATION

    ORDER AND BACKLOG TREND

    (Unaudited, $ in thousands)

     

     

     

     

     

     

     

     

     

     

     

    Q4 2024

     

    Q1 2025

     

    Q2 2025

     

    Q3 2025

     

    Trailing

    Twelve Months

     

    12/31/2024

     

    3/29/2025

     

    6/28/2025

     

    9/27/2025

     

    9/27/2025

    Sales

     

     

     

     

     

     

     

     

     

    Aerospace

    $

    188,549

     

    $

    191,375

     

    $

    193,626

     

    $

    192,725

     

    $

    766,275

    Test Systems

     

    19,991

     

     

    14,561

     

     

    11,052

     

     

    18,722

     

     

    64,326

    Total Sales

    $

    208,540

     

    $

    205,936

     

    $

    204,678

     

    $

    211,447

     

    $

    830,601

    Bookings

     

     

     

     

     

     

     

     

     

    Aerospace

    $

    182,474

     

    $

    267,715

     

    $

    150,636

     

    $

    191,859

     

    $

    792,684

    Test Systems

     

    13,430

     

     

    12,011

     

     

    26,390

     

     

    18,532

     

     

    70,363

    Total Bookings

    $

    195,904

     

    $

    279,726

     

    $

    177,026

     

    $

    210,391

     

    $

    863,047

    Backlog6

     

     

     

     

     

     

     

     

     

    Aerospace

    $

    537,563

     

    $

    613,903

     

    $

    570,913

     

    $

    572,459

     

     

    Test Systems

     

    61,666

     

     

    59,116

     

     

    74,454

     

     

    74,264

     

     

    Total Backlog

    $

    599,229

     

    $

    673,019

     

    $

    645,367

     

    $

    646,723

     

     

    N/A

    Book:Bill Ratio

     

     

     

     

     

     

     

     

     

    Aerospace

     

    0.97

     

     

    1.40

     

     

    0.78

     

     

    1.00

     

     

    1.03

    Test Systems

     

    0.67

     

     

    0.82

     

     

    2.39

     

     

    0.99

     

     

    1.09

    Total Book:Bill

     

    0.94

     

     

    1.36

     

     

    0.86

     

     

    1.00

     

     

    1.04

    ASTRONICS CORPORATION

    RECONCILIATION OF NET LOSS TO ADJUSTED EBITDA

    (Unaudited, $ in thousands)

     

     

     

     

     

     

     

     

     

    Consolidated

     

    Three Months Ended

     

    Nine Months Ended

     

    9/27/2025

     

    9/28/2024

     

    9/27/2025

     

    9/28/2024

    Net loss

    $

    (11,098

    )

     

    $

    (11,738

    )

     

    $

    (256

    )

     

    $

    (13,383

    )

    Add back (deduct):

     

     

     

     

     

     

     

    Interest expense

     

    2,920

     

     

     

    6,217

     

     

     

    9,167

     

     

     

    17,832

     

    Income tax (benefit) expense

     

    (1,226

    )

     

     

    6,565

     

     

     

    (43

    )

     

     

    4,940

     

    Depreciation and amortization expense

     

    5,163

     

     

     

    6,041

     

     

     

    16,129

     

     

     

    18,572

     

    Equity-based compensation expense

     

    1,439

     

     

     

    1,772

     

     

     

    5,341

     

     

     

    6,414

     

    Non-cash 401K contribution and quarterly bonus accrual

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    3,454

     

    Simplification and restructuring initiatives

     

    359

     

     

     

    259

     

     

     

    6,867

     

     

     

    1,033

     

    Legal reserve, settlements and recoveries

     

    —

     

     

     

    (332

    )

     

     

    9,732

     

     

     

    (332

    )

    Litigation-related legal expenses

     

    1,270

     

     

     

    5,558

     

     

     

    6,998

     

     

     

    13,680

     

    Acquisition-related expenses

     

    1,247

     

     

     

    —

     

     

     

    1,247

     

     

     

    —

     

    Loss on settlement of debt

     

    32,644

     

     

     

    6,987

     

     

     

    32,644

     

     

     

    6,987

     

    Non-cash reserves for customer bankruptcy

     

    —

     

     

     

    2,203

     

     

     

    —

     

     

     

    2,203

     

    Warranty reserve

     

    —

     

     

     

    3,527

     

     

     

    1,039

     

     

     

    3,527

     

    Adjusted EBITDA7

    $

    32,718

     

     

    $

    27,059

     

     

    $

    88,865

     

     

    $

    64,927

     

     

     

     

     

     

     

     

     

    Sales

    $

    211,447

     

     

    $

    203,698

     

     

    $

    622,061

     

     

    $

    586,886

     

    Adjusted EBITDA margin %

     

    15.5

    %

     

     

    13.3

    %

     

     

    14.3

    %

     

     

    11.1

    %

    Adjusted EBITDA is defined as net income before interest expense, income taxes, depreciation, amortization, and other adjustments. Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by sales. Adjusted EBITDA and Adjusted EBITDA Margin are not measures determined in accordance with GAAP and may not be comparable with Adjusted EBITDA and Adjusted EBITDA Margin as used by other companies. Nevertheless, the Company believes that providing non-GAAP financial measures, such as Adjusted EBITDA and Adjusted EBITDA Margin, are important for investors and other readers of the Company's financial statements.

    ASTRONICS CORPORATION

    RECONCILIATION OF OPERATING INCOME TO ADJUSTED OPERATING INCOME

    (Unaudited, $ in thousands)

     

     

     

     

     

     

     

     

     

    Consolidated

     

    Three Months Ended

     

    Nine Months Ended

     

    9/27/2025

     

    9/28/2024

     

    9/27/2025

     

    9/28/2024

    Income from operations

    $

    23,055

     

     

    $

    8,374

     

     

    $

    40,950

     

     

    $

    17,590

     

    Add back:

     

     

     

     

     

     

     

    Simplification and restructuring initiatives

     

    359

     

     

     

    259

     

     

     

    6,867

     

     

     

    1,033

     

    Legal reserve, settlements and recoveries

     

    —

     

     

     

    (332

    )

     

     

    9,732

     

     

     

    (332

    )

    Litigation-related legal expenses

     

    1,270

     

     

     

    5,558

     

     

     

    6,998

     

     

     

    13,680

     

    Acquisition-related expenses

     

    1,247

     

     

     

    —

     

     

     

    1,247

     

     

     

    —

     

    Non-cash reserves for customer bankruptcy

     

    —

     

     

     

    2,203

     

     

     

    —

     

     

     

    2,203

     

    Warranty reserve

     

    —

     

     

     

    3,527

     

     

     

    1,039

     

     

     

    3,527

     

    Adjusted operating income

    $

    25,931

     

     

    $

    19,589

     

     

    $

    66,833

     

     

    $

    37,701

     

     

     

     

     

     

     

     

     

    Sales

    $

    211,447

     

     

    $

    203,698

     

     

    $

    622,061

     

     

    $

    586,886

     

     

     

     

     

     

     

     

     

    Operating margin

     

    10.9

    %

     

     

    4.1

    %

     

     

    6.6

    %

     

     

    3.0

    %

    Adjusted operating margin

     

    12.3

    %

     

     

    9.6

    %

     

     

    10.7

    %

     

     

    6.4

    %

    Adjusted Operating Income is defined as income from operations as reported, adjusted for certain items. Adjusted Operating Margin is defined as Adjusted Operating Income divided by sales. Adjusted Operating Income and Adjusted Operating Margin are not measures determined in accordance with GAAP and may not be comparable with Adjusted Operating Income and Adjusted Operating Margin as used by other companies. Nevertheless, the Company believes that providing non-GAAP financial measures, such as Adjusted Operating Income and Adjusted Operating Margin, are important for investors and other readers of the Company's financial statements and assists in understanding the comparison of the current periods' income from operations to the historical periods' income from operations and operating margin, as well as facilitates a more meaningful comparison of the Company's income from operations and operating margin to that of other companies.

    ASTRONICS CORPORATION

    RECONCILIATION OF NET LOSS AND DILUTED LOSS PER SHARE

    TO ADJUSTED NET INCOME AND ADJUSTED DILUTED EARNINGS PER SHARE

    (Unaudited, $ in thousands except per share amounts)

     

     

     

     

     

     

     

     

     

    Consolidated

     

    Three Months Ended

     

    Nine Months Ended

     

    9/27/2025

     

    9/28/2024

     

    9/27/2025

     

    9/28/2024

    Net income (loss)

    $

    (11,098

    )

     

    $

    (11,738

    )

     

    $

    (256

    )

     

    $

    (13,383

    )

    Add back (deduct):

     

     

     

     

     

     

     

    Amortization of intangibles

     

    2,676

     

     

     

    3,188

     

     

     

    8,596

     

     

     

    9,728

     

    Simplification and restructuring initiatives

     

    359

     

     

     

    259

     

     

     

    6,867

     

     

     

    1,033

     

    Legal reserve, settlements and recoveries

     

    —

     

     

     

    (332

    )

     

     

    9,732

     

     

     

    (332

    )

    Litigation-related legal expenses

     

    1,270

     

     

     

    5,558

     

     

     

    6,998

     

     

     

    13,680

     

    Acquisition-related expenses

     

    1,247

     

     

     

    —

     

     

     

    1,247

     

     

     

    —

     

    Loss on settlement of debt

     

    32,644

     

     

     

    6,987

     

     

     

    32,644

     

     

     

    6,987

     

    Non-cash reserves for customer bankruptcy

     

    —

     

     

     

    2,203

     

     

     

    —

     

     

     

    2,203

     

    Warranty reserve

     

    —

     

     

     

    3,527

     

     

     

    1,039

     

     

     

    3,527

     

    Normalize tax rate8

     

    (7,694

    )

     

     

    2,511

     

     

     

    (16,749

    )

     

     

    (2,156

    )

    Adjusted net income

    $

    19,404

     

     

    $

    12,163

     

     

    $

    50,118

     

     

    $

    21,287

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Weighted average diluted shares outstanding (in thousands)

     

    35,423

     

     

     

    35,011

     

     

     

    35,372

     

     

     

    34,961

     

    Adjusted weighted average diluted shares outstanding (in thousands)9

     

    42,868

     

     

     

    35,696

     

     

     

    43,133

     

     

     

    35,538

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Diluted loss per share

    $

    (0.31

    )

     

    $

    (0.34

    )

     

    $

    (0.01

    )

     

    $

    (0.38

    )

    Adjusted diluted earnings per share10

    $

    0.49

     

     

    $

    0.34

     

     

    $

    1.28

     

     

    $

    0.60

     

    Adjusted Net Income and Adjusted Diluted EPS are defined as net income and diluted EPS as reported, adjusted for certain items, including amortization of intangibles, and also adjusted for a normalized tax rate. Adjusted Net Income and Adjusted Diluted EPS are not measures determined in accordance with GAAP and may not be comparable with the measures used by other companies. Nevertheless, the Company believes that providing non-GAAP financial measures, such as Adjusted Net Income and Adjusted Diluted EPS, are important for investors and other readers of the Company's financial statements and assists in understanding the comparison of the current periods' net income and diluted EPS to the historical periods' net income and diluted EPS, as well as facilitates a more meaningful comparison of the Company's net income and diluted EPS to that of other companies. The Company believes that presenting Adjusted Diluted EPS provides a better understanding of its earnings power inclusive of adjusting for the non-cash amortization of intangible assets, reflecting the Company's strategy to grow through acquisitions as well as organically.

    ASTRONICS CORPORATION

    RECONCILIATION OF SEGMENT OPERATING PROFIT (LOSS)

    TO ADJUSTED SEGMENT OPERATING PROFIT (LOSS)

    (Unaudited, $ in thousands)

     

     

     

     

    Three Months Ended

     

    Nine Months Ended

     

    9/27/2025

     

    9/28/2024

     

    9/27/2025

     

    9/28/2024

     

     

     

     

     

     

     

     

    Aerospace operating profit

    $

    31,167

     

     

    $

    14,251

     

     

    $

    71,470

     

     

    $

    45,628

     

    Simplification and restructuring initiatives

     

    —

     

     

     

    237

     

     

     

    6,508

     

     

     

    237

     

    Legal reserve, settlements and recoveries

     

    —

     

     

     

    (332

    )

     

     

    9,732

     

     

     

    (332

    )

    Litigation-related legal expenses

     

    982

     

     

     

    5,405

     

     

     

    5,902

     

     

     

    13,161

     

    Non-cash reserves for customer bankruptcy

     

    —

     

     

     

    2,203

     

     

     

    —

     

     

     

    2,203

     

    Warranty reserve

     

    —

     

     

     

    3,527

     

     

     

    1,039

     

     

     

    3,527

     

    Adjusted Aerospace operating profit

    $

    32,149

     

     

    $

    25,291

     

     

    $

    94,651

     

     

    $

    64,424

     

     

     

     

     

     

     

     

     

    Aerospace sales

    $

    192,725

     

     

    $

    177,554

     

     

    $

    577,726

     

     

    $

    518,135

     

     

     

     

     

     

     

     

     

    Aerospace margin

     

    16.2

    %

     

     

    8.0

    %

     

     

    12.4

    %

     

     

    8.8

    %

    Adjusted Aerospace margin

     

    16.7

    %

     

     

    14.2

    %

     

     

    16.4

    %

     

     

    12.4

    %

     

     

     

     

     

     

     

     

    Test Systems operating loss

    $

    (14

    )

     

    $

    (13

    )

     

    $

    (8,947

    )

     

    $

    (8,428

    )

    Simplification and restructuring initiatives

     

    359

     

     

     

    22

     

     

     

    359

     

     

     

    796

     

    Litigation-related legal expenses

     

    —

     

     

     

    153

     

     

     

    808

     

     

     

    519

     

    Adjusted Test Systems operating profit (loss)

    $

    345

     

     

    $

    162

     

     

    $

    (7,780

    )

     

    $

    (7,113

    )

     

     

     

     

     

     

     

     

    Test Systems sales

    $

    18,722

     

     

    $

    26,144

     

     

    $

    44,335

     

     

    $

    68,751

     

     

     

     

     

     

     

     

     

    Test Systems margin

     

    (0.1

    )%

     

     

    —

    %

     

     

    (20.2

    )%

     

     

    (12.3

    )%

    Adjusted Test Systems margin

     

    1.8

    %

     

     

    0.6

    %

     

     

    (17.5

    )%

     

     

    (10.3

    )%

    Adjusted Segment Operating Profit is defined as segment operating profit as reported, adjusted for certain items. Adjusted Segment Margin is defined as Adjusted Segment Operating Profit divided by segment sales. Adjusted Segment Operating Profit and Adjusted Segment Margin are not measures determined in accordance with GAAP and may not be comparable with Adjusted Segment Operating Profit and Adjusted Segment Margin as used by other companies. Nevertheless, the Company believes that providing non-GAAP financial measures, such as Adjusted Segment Operating Profit and Adjusted Segment Margin, are important for investors and other readers of the Company's financial statements and assists in understanding the comparison of the current periods' segment operating profit to the historical periods' segment operating profit and segment margin, as well as facilitates a more meaningful comparison of the Company's segment operating profit and segment margin to that of other companies.

    ______________ 

    1 Adjusted EBITDA, adjusted EBITDA margin, and adjusted segment operating margin are Non-GAAP financial measures. Please see the reconciliation of GAAP to non-GAAP financial measures in the tables that accompany this release.

     

    2 Adjusted gross profit, adjusted operating income, adjusted operating margin, adjusted segment operating profit, adjusted EBITDA, adjusted EBITDA margin, adjusted net income and adjusted diluted earnings per share ("EPS") are Non-GAAP financial measures. Please see the reconciliation of GAAP to non-GAAP financial measures in the tables that accompany this release.

     

    3 During the first quarter of 2025, the Company changed its financial statement presentation of research and development costs. These costs were previously included within Cost of Products Sold and were a factor in arriving at Gross Profit. The prior period amounts for Cost of Product Sold and Gross Profit have been adjusted from their original presentation for comparability purposes.

     

    4 All outstanding stock options, unvested restricted stock and shares potentially issuable upon conversion of the Company's convertible notes have been excluded from the computation of diluted earnings per share because the effect of their inclusion would be anti-dilutive.

     

    5 During the first quarter of 2025, the Company changed its financial statement presentation of research and development costs. These costs were previously included within Cost of Products Sold and were a factor in arriving at Gross Profit. The prior period amounts for Cost of Product Sold and Gross Profit have been adjusted from their original presentation for comparability purposes.

     

    6 Aerospace backlog of approximately $2.4 million was added in the third quarter of 2025 above related to the acquisition of Envoy Aerospace.

     

    7 In the first quarter 2024, it was assumed that annual incentive compensation would be paid in stock, and thus such amount ($1.4 million) was presented as an addback for Adjusted EBITDA purposes. In the fourth quarter of 2024, it was concluded that all annual incentive compensation amounts would be paid in cash, and thus the addback for the full year 2024 was eliminated. For comparative purposes, the addback was retrospectively removed from the calculation of Adjusted EBITDA for the nine months ended September 28, 2024.

     

    8 Applies a normalized tax rate of 25% to GAAP pre-tax income and non-GAAP adjustments above, which are each pre-tax.

     

    9 Includes outstanding equity compensation and shares potentially issuable under the Company's 5.5% convertible notes. No amounts are includable for the Company's 0% convertible notes because only the premium is potentially issuable in shares, and the instrument is not currently in the money.

     

    10 Net income for purposes of calculating adjusted diluted earnings per share includes addback of interest expense on the 5.5% convertible notes, net of income taxes, as required under the if-converted method.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251104723441/en/

    For more information:

    Company:

    Nancy L. Hedges, Chief Financial Officer

    Phone: (716) 805-1599

    Email: [email protected]

    Investor Relations:

    Deborah K. Pawlowski, Alliance Advisors LLC

    Phone: (716) 843-3908

    Email: [email protected]

    Get the next $ATRO alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATRO

    DatePrice TargetRatingAnalyst
    10/10/2025$60.00Buy
    Craig Hallum
    7/11/2025$49.00Hold → Buy
    Truist
    9/20/2021$19.00Neutral → Buy
    Colliers Securities
    More analyst ratings

    $ATRO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Astronics Corporation Reports 2025 Third Quarter Financial Results

    Third quarter sales increased 3.8% to $211.4 million driven by Aerospace growth of 8.5% to $192.7 million Third quarter net loss was $11.1 million, reflecting $32.6 million in refinancing-related charges; adjusted EBITDA1 was $32.7 million, or 15.5% of sales Aerospace operating margin was 16.2% and adjusted operating margin1 was 16.7% Solid quarterly bookings of $210.4 million and backlog of $646.7 million Generated $34.2 million in cash from operations Refinancing activities included the issuance of a convertible bond during the third quarter and the initiation of a cash flow revolver subsequent to quarter end Expect fourth quarter revenue to be $225 to $235 million, resulting

    11/4/25 4:15:00 PM ET
    $ATRO
    Military/Government/Technical
    Industrials

    Astronics Corporation Announces New $300 Million Revolving Credit Facility

    Astronics Corporation (NASDAQ:ATRO), a leading provider of advanced technologies for global aerospace, defense, and other mission critical industries, announced today that it has entered into a new $300 million senior secured, cash flow-based revolving credit facility (the "New Revolver"). The New Revolver matures in October 2030 and replaces the previous asset-based revolving credit facility that was scheduled to mature in 2027. The New Revolver, which enhances financial flexibility to support the Company's growth initiatives, also has an accordion feature, which allows the Company to request incremental commitments of up to $100 million plus additional incremental amounts so long as maxim

    10/22/25 4:15:00 PM ET
    $ATRO
    Military/Government/Technical
    Industrials

    Astronics Corporation Announces Third Quarter 2025 Financial Results Conference Call and Webcast

    Astronics Corporation (NASDAQ:ATRO), a leading supplier of advanced technologies and products to the global aerospace, defense, and other mission critical industries, announced that it will release its third quarter 2025 financial results after the close of financial markets on Tuesday, November 4, 2025. The Company will host a conference call and webcast that same day to review its financial and operating results and discuss its corporate strategies and outlook. A question-and-answer session will follow. Third Quarter 2025 Conference Call Tuesday, November 4, 2025 4:45 p.m. Eastern Time Phone: (201) 493-6784 Webcast: investors.astronics.com A telephonic replay will be available fro

    10/21/25 4:15:00 PM ET
    $ATRO
    Military/Government/Technical
    Industrials

    $ATRO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $ATRO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Pres Astronics Test Systems Mulato James exercised 4,300 units of $.01 PV Com Stk at a strike of $27.72 and exercised 1,387 units of $.01 PV CL B STK at a strike of $27.72, decreasing direct ownership by 92% to 2,453 units (SEC Form 4)

    4 - ASTRONICS CORP (0000008063) (Issuer)

    10/23/25 4:11:25 PM ET
    $ATRO
    Military/Government/Technical
    Industrials

    Executive VP & Pres-Aerospace Peabody Mark was granted 1,280 units of $.01 PV Com Stk, increasing direct ownership by 3% to 50,825 units (SEC Form 4)

    4 - ASTRONICS CORP (0000008063) (Issuer)

    10/2/25 4:22:59 PM ET
    $ATRO
    Military/Government/Technical
    Industrials

    Pres Astronics Test Systems Mulato James was granted 1,280 units of $.01 PV Com Stk, increasing direct ownership by 4% to 32,512 units (SEC Form 4)

    4 - ASTRONICS CORP (0000008063) (Issuer)

    10/2/25 4:22:16 PM ET
    $ATRO
    Military/Government/Technical
    Industrials

    Craig Hallum initiated coverage on Astronics with a new price target

    Craig Hallum initiated coverage of Astronics with a rating of Buy and set a new price target of $60.00

    10/10/25 8:36:00 AM ET
    $ATRO
    Military/Government/Technical
    Industrials

    Astronics upgraded by Truist with a new price target

    Truist upgraded Astronics from Hold to Buy and set a new price target of $49.00

    7/11/25 7:55:26 AM ET
    $ATRO
    Military/Government/Technical
    Industrials

    Astronics upgraded by Colliers Securities with a new price target

    Colliers Securities upgraded Astronics from Neutral to Buy and set a new price target of $19.00

    9/20/21 8:07:16 AM ET
    $ATRO
    Military/Government/Technical
    Industrials

    $ATRO
    SEC Filings

    View All

    SEC Form 10-Q filed by Astronics Corporation

    10-Q - ASTRONICS CORP (0000008063) (Filer)

    11/6/25 3:33:23 PM ET
    $ATRO
    Military/Government/Technical
    Industrials

    Astronics Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - ASTRONICS CORP (0000008063) (Filer)

    11/4/25 4:17:26 PM ET
    $ATRO
    Military/Government/Technical
    Industrials

    Astronics Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - ASTRONICS CORP (0000008063) (Filer)

    10/22/25 4:22:09 PM ET
    $ATRO
    Military/Government/Technical
    Industrials

    $ATRO
    Financials

    Live finance-specific insights

    View All

    Astronics Corporation Reports 2025 Third Quarter Financial Results

    Third quarter sales increased 3.8% to $211.4 million driven by Aerospace growth of 8.5% to $192.7 million Third quarter net loss was $11.1 million, reflecting $32.6 million in refinancing-related charges; adjusted EBITDA1 was $32.7 million, or 15.5% of sales Aerospace operating margin was 16.2% and adjusted operating margin1 was 16.7% Solid quarterly bookings of $210.4 million and backlog of $646.7 million Generated $34.2 million in cash from operations Refinancing activities included the issuance of a convertible bond during the third quarter and the initiation of a cash flow revolver subsequent to quarter end Expect fourth quarter revenue to be $225 to $235 million, resulting

    11/4/25 4:15:00 PM ET
    $ATRO
    Military/Government/Technical
    Industrials

    Astronics Corporation Announces Third Quarter 2025 Financial Results Conference Call and Webcast

    Astronics Corporation (NASDAQ:ATRO), a leading supplier of advanced technologies and products to the global aerospace, defense, and other mission critical industries, announced that it will release its third quarter 2025 financial results after the close of financial markets on Tuesday, November 4, 2025. The Company will host a conference call and webcast that same day to review its financial and operating results and discuss its corporate strategies and outlook. A question-and-answer session will follow. Third Quarter 2025 Conference Call Tuesday, November 4, 2025 4:45 p.m. Eastern Time Phone: (201) 493-6784 Webcast: investors.astronics.com A telephonic replay will be available fro

    10/21/25 4:15:00 PM ET
    $ATRO
    Military/Government/Technical
    Industrials

    Astronics Corporation Reports Record Aerospace Segment Sales in 2025 Second Quarter

    Second quarter sales increased 3.3% to $204.7 million driven by Aerospace growth of 9.4% to a record $193.6 million Second quarter net income was $1.3 million, or $0.04 per diluted share; adjusted EBITDA1 was $25.4 million, or 12.4% of sales Aerospace operating margin was 9.3% including investments in simplification initiatives and legal fee reimbursement; adjusted operating margin1 was 16.3% Test Systems restructuring cost savings masked by $6.9 million impact to profitability from estimated cost to complete adjustments Solid quarterly bookings of $177.0 million and backlog of $645.4 million Raised lower end of revenue guidance to range of $840 million to $860 million for

    8/6/25 4:15:00 PM ET
    $ATRO
    Military/Government/Technical
    Industrials

    $ATRO
    Leadership Updates

    Live Leadership Updates

    View All

    Astronics Corporation Appoints Fay West to its Board of Directors

    Astronics Corporation (NASDAQ:ATRO), a leading provider of advanced technologies for global aerospace, defense and other mission critical industries, announced the appointment of Fay West to its Board of Directors, effective February 6, 2025. Ms. West brings over two decades of financial leadership experience across various industries. Since April 2021, she has served as Senior Vice President and Chief Financial Officer at Tennant Company (NYSE:TNC), a global leader in designing, manufacturing, and marketing solutions that help create a cleaner, safer, and healthier world. Peter J. Gundermann, Chairman, President and CEO, commented, "We are thrilled to welcome Fay to our Board of Director

    2/7/25 8:00:00 AM ET
    $ATRO
    $KWR
    $TNC
    Military/Government/Technical
    Industrials
    Major Chemicals
    Industrial Machinery/Components

    Astronics Corporation Appoints Nancy L. Hedges as Chief Financial Officer Effective January 4, 2025

    To succeed David C. Burney upon his retirement Astronics Corporation (NASDAQ:ATRO) ("Astronics" or the "Company") today announced that its Board of Directors has appointed Nancy L. Hedges, currently Controller and Principal Accounting Officer, to Vice President and Chief Financial Officer effective upon the retirement of David C. Burney, the Company's current CFO, on January 3, 2025. Peter J. Gundermann, Chairman, President and Chief Executive officer, commented, "Nancy has attained strong command of our financial landscape across the broad range of our business, and has been intimately involved in our financial strategies and recent financing activities. She has an excellent working know

    10/15/24 8:30:00 AM ET
    $ATRO
    Military/Government/Technical
    Industrials

    Astronics Corporation Appoints Linda O'Brien to Its Board of Directors

    Astronics Corporation (NASDAQ:ATRO), a leading supplier of advanced technologies and products to the global aerospace and defense industries, today announced the appointment of Linda O'Brien to its Board of Directors, effective February 24, 2023. Ms. O'Brien is Vice President and Chief Engineer at Lockheed Martin Aeronautics, a position she has held since 2021. She was originally employed by Lockheed/General Dynamics from 1986 to 2006, rejoining the company in 2016. She has held a variety of positions including Program Management Director and Deputy Vice President of ISR and Unmanned Systems, Engineering Director- Deputy to the Vice President of Engineering and Technology and Engineering Di

    3/2/23 6:30:00 AM ET
    $ATRO
    Military/Government/Technical
    Industrials

    $ATRO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Astronics Corporation

    SC 13G - ASTRONICS CORP (0000008063) (Subject)

    12/12/24 5:27:21 PM ET
    $ATRO
    Military/Government/Technical
    Industrials

    Amendment: SEC Form SC 13G/A filed by Astronics Corporation

    SC 13G/A - ASTRONICS CORP (0000008063) (Subject)

    11/14/24 11:42:53 AM ET
    $ATRO
    Military/Government/Technical
    Industrials

    SEC Form SC 13G/A filed by Astronics Corporation (Amendment)

    SC 13G/A - ASTRONICS CORP (0000008063) (Subject)

    2/13/24 4:58:57 PM ET
    $ATRO
    Military/Government/Technical
    Industrials